Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic

Journal of the American Academy of Dermatology

Volumn 61, Issue 2, 2009, Pages 271-275

  Herro, Elise ^a   DiCaudo, David J ^a   Davis, Mark D P ^b   Weaver, Amy L ^b   Swanson, David L ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

B cell lymphoma; cutaneous T cell lymphoma; mycosis fungoides; S zary syndrome

Indexed keywords

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MEDICAL RECORD REVIEW; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SECOND CANCER;

ACADEMIC MEDICAL CENTERS; ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; BIOPSY, NEEDLE; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; NEOPLASM STAGING; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 67650098171     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.03.033     Document Type: Article

References (21)

1. Olsen E.A., Delzell E., and Jegasothy B.V. Second malignancies in cutaneous T cell lymphoma. J Am Acad Dermatol 10 (1984) 197-204
2. Scarisbrick J.J., Child F.J., Evans A.V., Fraser-Andrews E.A., Spittle M., and Russell-Jones R. Secondary malignant neoplasms in 71 patients with Sézary syndrome. Arch Dermatol 135 (1999) 1381-1385
3. Vakeva L., Pukkala E., and Ranki A. Increased risk of secondary cancers in patients with primary cutaneous T cell lymphoma. J Invest Dermatol 115 (2000) 62-65
4. In: Jaffee E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). World Health Organization classification of tumors: pathology and genetics of tumors of hematopoietic and lymphoid tissues. Lyon (France) (2001), IARC Press
5. Criscione V.D., and Weinstock M.A. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol 143 (2007) 854-859
6. Morton L.M., Wang S.S., Devesa S.S., Hartge P., Weisenburger D.D., and Linet M.S. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107 (2006) 265-276
7. US Census Bureau. Available from: URL:http://www.census.gov/. Accessed September 26, 2008.
8. Barzilai A., Trau H., David M., Feinmesser M., Bergman R., Shapiro D., et al. Mycosis fungoides associated with B-cell malignancies. Br J Dermatol 155 (2006) 379-386
9. Hallermann C., Kaune K.M., Tiemann M., Kunze E., Griesinger F., Mitteldorf C., et al. High frequency of primary cutaneous lymphomas associated with lymphoproliferative disorders of different lineage. Ann Hematol 86 (2007) 509-515
10. Brownell I., Etzel C.J., Yang D.J., Taylor S.H., and Duvic M. Increased malignancy risk in the cutaneous T-cell lymphoma patient population. Clin Lymphoma Myeloma 8 (2008) 100-105
11. Bryant E., Ronan S.G., and Iossifides I.A. Plasma cell myeloma in a patient with a cutaneous T-cell lymphoma. Cancer 50 (1982) 2122-2125
12. Sheibani K., Forman S.J., Winberg C.D., and Rappaport H. Coincidence of B-cell chronic lymphocytic leukemia and cutaneous T-cell lymphoma (mycosis fungoides): immunologic characterization by monoclonal antibodies. Blood 62 (1983) 1176-1181
13. van der Akker T.W., van der Willigan A.H., van der Kwast T.H., and van Dongen J.J.M. Cutaneous T-cell lymphoma after successful treatment of follicular B-cell lymphoma. Br J Dermatol 123 (2006) 266-267
14. Boice Jr. J.D., and Travis L.B. Body wars: effect of friendly fire (cancer therapy). J Natl Cancer Inst 87 (1995) 705-706
15. Krishnan B., and Morgan G.J. Non-Hodgkin lymphoma secondary to cancer chemotherapy. Cancer Epidemiol Biomarkers Prev 16 (2007) 377-380
16. Lee M., Roldan M.C., Haskell M.K., McAdam S.R., and Hartley J.A. In vitro photoinduced cytotoxicity and DNA binding properties of psoralen and coumarin conjugates of netropsin analogues: DNA sequence-directed alkylation and cross-link formation. J Med Chem 37 (1994) 1208-1213
17. Hemminki K., Jiang Y., and Steineck G. Skin cancer and non-Hodgkin's lymphoma as second malignancies: markers of impaired immune function?. Eur J Cancer 39 (2003) 223-229
18. Inokuchi T., Shincho M., Moriwaki Y., Ka T., Takahashi S., Tsutsumi Z., et al. Coexistent B-cell lymphoma and cutaneous T-cell lymphoma. Intern Med 45 (2006) 641-647
19. Ng A.K., and Travis L.B. Second primary cancers: an overview. Hematol Oncol Clin North Am 22 (2008) 271-289 vii
20. Opelz G., and Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 4 (2004) 222-230
21. Salahuddin S.Z., Markham P.D., Lindner S.G., Gootenberg J., Popovic M., Hemmi H., et al. Lymphokine production by cultured human T cells transformed by human T-cell leukemia-lymphoma virus-I. Science 223 (1984) 703-707